The price reduction is being enabled by cutting ... a basal insulin that is biosimilar to and interchangeable with Lantus (insulin glargine) injection. Priced at $92 per five pack of KwikPens ...

Toujeo is the next generation, longer-acting version of Lantus (insulin glargine ... at a discount of 15-20 per cent to Sanofi's brand price. Biosimilars are expected in Western Europe shortly ...

Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, ...

They need insulin simply to survive ... Express Scripts reported that the price of Lantus and Humalog rose 22.7% and 19.9%, respectively, from 2014 to 2015. In 2014, Sanofi got $6.93 billion in ...

This includes Admelog, Lantus, Toujeo ... of the nation’s top manufacturers of insulin and other diabetes medications, ...